Open letter: Urgent call to amend the Temporary State Aid Framework to achieve the Recovery and Resiliency Facility objectives

17 November 2021

Adjustments to IP framework needed to improve access to medicines in Europe

16 November 2021

Access to generic and biosimilar medicines can be improved with coherent proposals for IP […]

Margaritis Schinas and Adrian Van Den Hoven visited ELPEN

15 November 2021

Access to medicines critical in European Parliament vote on EU IP action plan

12 November 2021

The European Parliament Own Initiative Report on an intellectual property […]

IGBA Calls on all Stakeholders to Join the Biosimilars Movement on Advancing Access

1 November 2021

European Commission pilot project on repurposing brings value added innovation to life

28 October 2021

Innovation on existing, well-known molecules through repurposing can deliver huge benefits for patients and address unmet medical needs sustainably. Today […]

Digitalisation the key to efficient EU pharmaceutical regulation and easing of localised drug shortages

27 October 2021

“Digitalisation the key to efficient EU pharmaceutical regulation and easing […]

“Central Role For Industry Beckons As Europe Rebuilds After COVID” – Interview to Rebecca Guntern

25 October 2021

Generics And Biosimilars Must Become A Central Policy Pillar, Says […]

Smart use of off-patent medicines will be critical to rebuild healthcare systems successfully post-Covid

7 October 2021

Baton passes from Christoph Stoller to Rebecca Guntern as President of Medicines for Europe

1 October 2021

Rebecca Guntern (Sandoz) today begins an interim term as President […]